Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Bevacizumab 0.05% Eye Drops for Preventing Recurrent Pterygium
TCTR20110000018Phase 3Recruiting
- Sponsor
- Chulalongkorn University
- Start
- Dec 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in pterygium, sponsored by Chulalongkorn University. Started Dec 2010; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
pterygium
Beyond the preview
Go deeper on TCTR20110000018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20110000018.